← back to search

Aayushi Srivastava

German Cancer Research Center · DE
Area of research
Molecular Biology · Pathology and Forensic Medicine
Research interest
Research interests include Genetic factors in colorectal cancer, Thyroid Cancer Diagnosis and Treatment, RNA modifications and cancer, and Cancer-related gene regulation.
h-index
8
citations
188
works
21
NIH funding
primary concept
email

Recent publications

Prioritization of predisposition genes for familial non-medullary thyroid cancer by whole-genome sequencing
European Journal of Endocrinology 2025cited by 2position: firstdoi
Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer
International Journal of Molecular Sciences 2022cited by 10position: middledoi
Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer
Molecular Genetics and Genomics 2022cited by 4position: middledoi
Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer
Frontiers in Endocrinology 2021cited by 18position: firstdoi
Whole Exome Sequencing Identifies APCDD1 and HDAC5 Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer
International Journal of Molecular Sciences 2021cited by 14position: middledoi
Whole Exome Sequencing Identifies APCDD1 and HDAC5 Genes as Potentially Cancer Predisposing in Familial Colorectal Cancer
Preprints.org 2021cited by 2position: middledoi
Whole Exome Sequencing Identifies Novel Germline Variants of SLC15A4 Gene as Potentially Cancer Predisposing in Familial Colorectal Cancer
Preprints.org 2021cited by 2position: middledoi
A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer
Journal of Personalized Medicine 2021cited by 1position: middledoi
A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal Cancer
Preprints.org 2021cited by 1position: middledoi
A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer
Cancers 2020cited by 43position: firstdoi
Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing
Frontiers in Bioengineering and Biotechnology 2020cited by 16position: firstdoi
A novel germline mutation in the <i>POT1</i> gene predisposes to familial non-medullary thyroid cancer
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 8position: firstdoi
Informing patients about their mutation tests: CDKN2A c.256G&gt;A in melanoma as an example
Hereditary Cancer in Clinical Practice 2020cited by 4position: middledoi
Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways
Biomolecules 2019cited by 35position: firstdoi
Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways
Preprints.org 2019cited by 10position: firstdoi
Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing
medRxiv 2019cited by 4position: firstdoi
Abstract 4172: Identification of familial Hodgkin lymphoma predisposing genes by whole genome sequencing
Cancer Research 2019cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Obul Reddy Bandapalli · German Cancer Research Center17 papers (2019–2025)Kari Hemminki · Lund University17 papers (2019–2025)Asta Försti · German Cancer Research Center16 papers (2019–2025)Abhishek Kumar · Manipal Academy of Higher Education15 papers (2019–2025)Nagarajan Paramasivam · National Center for Tumor Diseases13 papers (2019–2025)Beiping Miao · German Cancer Research Center11 papers (2020–2025)Diamanto Skopelitou · German Cancer Research Center11 papers (2020–2025) · 10 papers (2019–2022)Jan Lubiński · Radboud University Medical Center10 papers (2019–2022)Matthias Schlesner · University of Augsburg7 papers (2021–2022)Sara Giangiobbe · Vita-Salute San Raffaele University7 papers (2019–2022) · 5 papers (2019–2021) · 5 papers (2021–2022)Mathias Witzens‐Harig · Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie3 papers (2019–2020) · 2 papers (2021–2025)Wolfgang Behnisch · University Hospital Heidelberg2 papers (2019–2020)Varun Kumar · University Hospital Heidelberg2 papers (2020–2020)Sivaramakrishna Rachakonda · Universitätsklinikum Tübingen1 papers (2020–2020) · 1 papers (2022–2022) · 1 papers (2019–2019)